Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2000 | 12-1999 | 09-1999 | 06-1999 | 03-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 102,050 | 85,570 | 55,810 | 65,830 |
| Marketable Securities | N/A | 13,860 | 28,030 | 34,090 | 20,830 |
| Receivables | N/A | 180,860 | 125,190 | 129,610 | 118,190 |
| Inventories | N/A | 108,530 | 106,210 | 108,620 | 102,640 |
| Other current assets | 0 | 29,410 | 28,750 | 30,380 | 47,250 |
| TOTAL | $N/A | $434,710 | $373,750 | $358,510 | $354,740 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 200,580 |
| Investments And Advances | 0 | 291,440 | 423,130 | 535,820 | 308,110 |
| Other Non-Current Assets | 0 | 573,740 | 520,680 | 495,790 | 474,340 |
| TOTAL | $N/A | $865,180 | $943,810 | $1,031,610 | $983,030 |
| Total Assets | $N/A | $1,438,750 | $1,453,120 | $1,524,400 | $1,267,590 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,690 | 1,920 | 1,970 | 2,100 |
| Accounts payable and accrued liabilities | 0 | 56,480 | 62,520 | 67,950 | 77,870 |
| Other current liabilities | N/A | 37,450 | 16,200 | 15,950 | 15,000 |
| TOTAL | $N/A | $129,180 | $91,980 | $92,070 | $113,140 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 149,500 | 149,690 | 150,320 | 153,810 |
| aiOther Non-Current Liabilities | 0 | 18,440 | 8,240 | 7,490 | 5,400 |
| TOTAL | $N/A | $255,000 | $303,460 | $346,920 | $257,070 |
| Total Liabilities | $N/A | $384,190 | $395,460 | $439,000 | $370,220 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 310 | 310 | 310 | 310 |
| Retained earnings | N/A | 549,000 | 475,950 | 439,250 | 393,090 |
| Other shareholders' equity | 0 | 107,540 | 187,330 | 255,490 | 124,970 |
| TOTAL | $N/A | $1,054,550 | $1,057,660 | $1,085,390 | $897,370 |
| Total Liabilities And Equity | $0 | $1,438,740 | $1,453,120 | $1,524,390 | $1,267,590 |